CVC Capital Partners VII, LP, a fund managed by CVC Capital Partners Limited, signed a definitive agreement to acquire an unknown majority interest in MedRisk, Inc. from Carlyle Partners VI, L.P., a fund managed by The Carlyle Group Inc. (NasdaqGS:CG) on February 22, 2021. The MedRisk team, including founder Shelley Boyce, Executive Chairman Mike Ryan and Chief Executive Officer Ken Martino, will reinvest in the company. The Carlyle Group, MedRisk's current majority owner, will retain a significant stake and maintain joint control in partnership with CVC.

Equity capital for the investment will come from CVC Fund VII and Carlyle Partners VI. The transaction is subject to customary closing conditions and receipt of required regulatory approvals and is expected to close in the second quarter of 2021. Centerview Partners and Truist Securities acted as financial advisors to MedRisk and Carlyle.

Jennifer Chu, Kevin Rinke, Scott B. Selinger, Jeffrey E. Ross, Henry Lebowitz, Peter A. Furci, Jennifer L. Chu and Lawrence K. Cagney of Debevoise & Plimpton LLP acted as legal advisors to MedRisk and Carlyle. Justin Wagstaff, Sang I. Ji, Binoy Dharia, Oliver Brahmst, Brian Smarsh and Tal Marnin of White & Case LLP acted as legal advisors for CVC Capital Partners. Heather Waters Borthwick of Shearman & Sterling (London) LLP acted as legal advisor to CVC Capital Partners Limited.

Greg Olsen, Peter Mucchetti, Edita Katuscakova and Sophie Scholl of Clifford Chance acted as legal advisor to CVC Capital Partners.